Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Silk Road Medical IncSILK · Entity 87417 | Director | July 08, 2020 | July 13, 2020 |
| Sotera Health CoSHC · Entity 3869 | Director | May 22, 2026 | May 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Silk Road Medical Inc
Report date July 08, 2020 · Filed July 13, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 644 |
Reported balance
After 2020-07-08 transaction · row 1
1 source rowRow 1 · 2020-07-08 · Grant · Acquired 644 · Balance 644 F1: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. All of the RSUs vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2021 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $44.62 · Expires 2030-07-08 | Direct | 4,482 |
Reported balance
After 2020-07-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-07-08 · Grant · Acquired 4,482 · Balance 4,482 F2: All of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2021 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $44.62 · Expires 2030-07-08 | Direct | 2,390 |
Reported balance
After 2020-07-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-07-08 · Grant · Acquired 2,390 · Balance 2,390 F3: The shares subject to the options represent cash retainer and any additional fees that the Reporting Person elected to receive in the form of stock options. F4: One fourth of the shares subject to the option shall vest on each of September 5, 2020, December 5, 2020, March 5, 2021, and the date of the Issuer's 2021 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. All of the RSUs vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2021 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date.
F2: All of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2021 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date.
F3: The shares subject to the options represent cash retainer and any additional fees that the Reporting Person elected to receive in the form of stock options.
F4: One fourth of the shares subject to the option shall vest on each of September 5, 2020, December 5, 2020, March 5, 2021, and the date of the Issuer's 2021 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date.
Sotera Health Co
Report date May 22, 2026 · Filed May 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par value per share ("Common Stock")SEC Table I · non-derivative | Direct | 95,751 |
Reported balance
After 2026-05-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-22 · Grant · Acquired 14,970 · Balance 95,751 F1: These securities consist of 14,970 Restricted Stock Units ("RSUs") that were granted on May 22, 2026, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. F2: These securities consist of 14,970 RSUs and 80,961 shares of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities consist of 14,970 Restricted Stock Units ("RSUs") that were granted on May 22, 2026, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date.
F2: These securities consist of 14,970 RSUs and 80,961 shares of Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2026 Filed May 27, 2026 21:23 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share ("Common Stock") | 14,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-242188 · ownership.xml · nonDerivative · entry 1 Chen Ruoxi · CIK 0001769832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,751 F1 · shares: These securities consist of 14,970 Restricted Stock Units ("RSUs") that were granted on May 22, 2026, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. F2 · balance_after: These securities consist of 14,970 RSUs and 80,961 shares of Common Stock. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:38 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share ("Common Stock") | 19,132 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-077779 · ownership.xml · nonDerivative · entry 1 Chen Ruoxi · CIK 0001769832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,781 F1 · shares: These securities consist of 19,132 restricted stock units ("RSUs") that were granted on May 22, 2025, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incenctive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. F2 · balance_after: These securities consist of 19,132 RSUs and 61,649 shares of Common Stock. Read SEC document |
| May 24, 2024 Filed May 29, 2024 20:26 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share ("Common Stock") | 20,089 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-065968 · ownership.xml · nonDerivative · entry 1 Chen Ruoxi · CIK 0001769832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,649 F1 · shares: These securities consist of 20,089 Restricted Stock Units ("RSUs") that were granted on May 24, 2024, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. F2 · balance_after: These securities consist of 20,089 RSUs and 41,560 shares of Common Stock. Read SEC document |
| May 26, 2023 Filed May 31, 2023 20:56 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share (Common Stock) | 15,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033124 · doc4.xml · nonDerivative · entry 1 Chen Ruoxi · CIK 0001769832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,560 F1 · shares: These securities consist of 15,712 Restricted Stock Units ("RSUs") that were granted on May 26, 2023, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. F2 · balance_after: These securities consist of 15,712 RSUs and 25,848 shares of Common Stock. Read SEC document |
| May 27, 2022 Filed May 31, 2022 21:46 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share ("Common Stock") | 10,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001822479-22-000046 · wf-form4_165403358893630.xml · nonDerivative · entry 1 Chen Ruoxi · CIK 0001769832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,848 F1 · shares: These securities consist of 10,643 Restricted Stock Units ("RSUs") that were granted on May 27, 2022, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. F2 · balance_after: These securities consist of 10,643 RSUs and 15,205 shares of Common Stock. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 22:49 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share ("Common Stock") | 9,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001822479-21-000035 · wf-form4_162258765139324.xml · nonDerivative · entry 1 Chen Ruoxi · CIK 0001769832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,205 F1 · shares: These securities consist of 9,336 Restricted Stock Units ("RSUs") that were granted on May 28, 2021, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. F2 · balance_after: These securities consist of 9,336 RSUs and 5,869 shares of Common Stock. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 23:45 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share ("Common Stock") | 5,869 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-032060 · doc4.xml · nonDerivative · entry 1 Chen Ruoxi · CIK 0001769832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,869 F1 · shares: These securities consist of 5,869 Restricted Stock Units ("RSUs") that were granted on November 20, 2020, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. Read SEC document |
| July 08, 2020 Filed Jul 13, 2020 16:03 UTC | Silk Road Medical Inc SILK · Entity 87417 | GrantOption (right to buy) · Derivative | 2,390 | $0.00 Strike: $44.62 | $0.00 |
DisclosureSEC source: 0001593968-20-001627 · primary_01.xml · derivative · entry 3 Chen Ruoxi · CIK 0001769832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,390 Underlying: Common Stock · 2,390 shares Expires 2030-07-08 F3 · shares: The shares subject to the options represent cash retainer and any additional fees that the Reporting Person elected to receive in the form of stock options. F4 · derivative.exercise_date: One fourth of the shares subject to the option shall vest on each of September 5, 2020, December 5, 2020, March 5, 2021, and the date of the Issuer's 2021 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| July 08, 2020 Filed Jul 13, 2020 16:03 UTC | Silk Road Medical Inc SILK · Entity 87417 | GrantOption (right to buy) · Derivative | 4,482 | $0.00 Strike: $44.62 | $0.00 |
DisclosureSEC source: 0001593968-20-001627 · primary_01.xml · derivative · entry 2 Chen Ruoxi · CIK 0001769832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,482 Underlying: Common Stock · 4,482 shares Expires 2030-07-08 F2 · derivative.exercise_date: All of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2021 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| July 08, 2020 Filed Jul 13, 2020 16:03 UTC | Silk Road Medical Inc SILK · Entity 87417 | GrantCommon Stock | 644 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-001627 · primary_01.xml · nonDerivative · entry 1 Chen Ruoxi · CIK 0001769832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 644 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. All of the RSUs vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2021 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 19:11 UTC | Silk Road Medical Inc SILK · Entity 87417 | GrantDirector Stock Option (Right to buy) · Derivative | 2,939 | $0.00 Strike: $46.15 | $0.00 |
DisclosureSEC source: 0001209191-19-035654 · doc4.xml · derivative · entry 1 Chen Ruoxi · CIK 0001769832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,939 Underlying: Common Stock · 2,939 shares Expires 2029-06-05 F1 · derivative.exercise_date: One fourth of the shares subject to the option shall vest on each of September 1, 2019, December 1, 2019, March 1, 2020, and the date of the Issuer's 2020 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| April 03, 2019 Filed Apr 5, 2019 21:30 UTC | Silk Road Medical Inc SILK · Entity 87417 | GrantDirector Stock Option (Right to buy) · Derivative | 8,910 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001628280-19-003986 · wf-form4_155451422707241.xml · derivative · entry 1 Chen Ruoxi · CIK 0001769832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,910 Underlying: Common Stock · 8,910 shares Expires 2029-04-03 F1 · derivative.exercise_date: One third of the shares subject to the option shall vest on May 3, 2020 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.